Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • shilez
    Member
    • Jun 2010
    • 10

    #1

    DEXSeq python script error message

    When I try to run dexseq_prepare_annotation.py, I got a python error at line 29:
    exons[f.iv] += ( f.attr['gene_id'], f.attr['transcript_id'] )
    TypeError: unsupported operand type(s) for +=: 'StepVector' and 'tuple'
    Anyone has any idea how to fix it?
  • Jane M
    Senior Member
    • Aug 2011
    • 239

    #2
    I have no idea, but I managed to run this script, so there is no error in it. Nevertheless, if I remeber well, a certain version of python is needed...

    Comment

    • Simon Anders
      Senior Member
      • Feb 2010
      • 995

      #3
      Could it be that you have an outdated version of HTSeq installed?

      Comment

      • shilez
        Member
        • Jun 2010
        • 10

        #4
        Thank you, guys.
        Once I update the HTSeq, it works fine.
        However, I do got the error message "Same name found on two chromosomes".
        Does it mean we need to remove the duplicated genes from the annotation gtf file first before running dexseq_prepare_annotation.py?

        *and also an error from HTSeq
        ValueError: start is larger than end
        Last edited by shilez; 09-08-2011, 10:57 AM.

        Comment

        • areyes
          Senior Member
          • Aug 2010
          • 165

          #5
          The first error can be solved by adding an additional ID tag to these genes. (e.g. if the gene is called A, you could write A_dup1 and A_dup2 foreach one so that the gene names become unique). They are usually not to many in the annotation files. (I have done it manually for the ensembl mouse gtf annotation).

          The second I have also seen it, for some genes, the start value is higher to the end value. I guess this is a mistake in the gtf files. Can be corrected just by shifting the columns in this cases. Also, there are usually not to many.

          Comment

          Latest Articles

          Collapse

          • SEQadmin2
            Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
            by SEQadmin2



            CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

            Despite this, “CRISPR helped turn genome editing from a specialized technique into
            ...
            07-31-2026, 11:01 AM
          • SEQadmin2
            Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
            by SEQadmin2


            Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

            The systematic characterization of the human proteome has
            ...
            07-20-2026, 11:48 AM
          • SEQadmin2
            Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
            by SEQadmin2



            Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
            ...
            07-09-2026, 11:10 AM

          ad_right_rmr

          Collapse

          News

          Collapse

          Topics Statistics Last Post
          Started by SEQadmin2, Yesterday, 07:41 AM
          0 responses
          12 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 08-03-2026, 10:13 AM
          0 responses
          25 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-31-2026, 02:55 AM
          0 responses
          38 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-24-2026, 12:17 PM
          0 responses
          25 views
          0 reactions
          Last Post SEQadmin2  
          Working...